Paragraf Localizes Quantum Supply Chain
Paragraf
Paragraf is turning geography into a product and supply chain advantage, not just a sales footprint. Its UK base, new Huntingdon wafer facility, and U.S. presence created through the Cardea Bio acquisition let it serve customers closer to where quantum labs, EV programs, and biosensor partners operate, while reducing dependence on cross border movement of sensitive graphene devices, advanced materials know how, and quantum related components that increasingly sit inside tighter export control regimes.
-
The practical reason local presence matters is that Paragraf sells physical sensor chips that get built into customer test setups and battery systems. Its Graphene Hall Sensors run from millikelvin temperatures up to 350K, so a quantum lab or EV engineer is buying parts that must be qualified in local workflows, not generic software shipped globally.
-
The U.S. acquisition was more than market entry. Cardea Bio became Paragraf USA, adding a San Diego facility, team, and operations. That gave Paragraf manufacturing and commercial infrastructure on both sides of the Atlantic, which is useful when export rules now cover quantum computing items, related equipment, components, materials, software, and technology.
-
This also sharpens Paragraf's position against incumbents like Lake Shore Cryotronics. Lake Shore is strong in cryogenic instrumentation and has a broad global sales network, especially in Europe, while Paragraf is differentiating with graphene sensors that can remove extra amplification and shielding steps in demanding cryogenic measurement setups.
The next phase is a more regionalized deep tech supply chain, where quantum and advanced materials companies place manufacturing, applications support, and customer integration closer to end markets. Paragraf's recent 6 inch wafer milestone in Huntingdon and its U.S. operating base suggest it is building the footprint needed to become a standard component supplier across multiple regulated markets.